insights_auto
Why is 207940 down 2.62%?
Dive Deeperchevron_right
207940:KRX
Samsung Biologics Co Ltd
â‚©1,411,000.00
arrow_downward
-2.62%(-38,000.00) 1D
Nov 13, 3:30:28 PM GMT+9 · KRW
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 207940...
Open
â‚©1,437,000
High
â‚©1,456,000
Low
â‚©1,406,000
Mkt. cap
68.52T
Avg. vol.
76.96K
Volume
49.11K
P/E ratio
30.74
52-wk high
â‚©1,973,600
52-wk low
â‚©1,150,000
EPS
â‚©45,897
Shares outstanding
46.29M
No. of employees
5K
Open
â‚©1,437,000
High
â‚©1,456,000
Low
â‚©1,406,000
Mkt. cap
68.52T
Avg. vol.
76.96K
Volume
49.11K
P/E ratio
30.74
52-wk high
â‚©1,973,600
52-wk low
â‚©1,150,000
EPS
â‚©45,897
Shares outstanding
46.29M
No. of employees
5K
News stories
From web sources and news partners
BigGo Finance
·
1 day ago
South Korea's Samsung Bioepis Pays First Interim Dividend of approximately $78.3 Million Entirely to Holding Company
Seoul Economic Daily
·
2 days ago
Samsung Biologics Draws 96.8% Subscription in 2.67 Trillion Won Share Sale
Profile
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
About Samsung Biologics Co Ltd
CEOJohn Rim
Employees5.33K
Founded2011
Headquarters-
SectorHealth Care
Industry-
Websitesamsungbiologics.com